Home/Filings/4/0001209191-24-001515
4//SEC Filing

Feener Edward P. 4

Accession 0001209191-24-001515

CIK 0001348911other

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 4:26 PM ET

Size

5.8 KB

Accession

0001209191-24-001515

Insider Transaction Report

Form 4
Period: 2024-01-11
Feener Edward P.
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2024-01-11$13.03/sh22,679$295,51439,828 total
Footnotes (2)
  • [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated July 20, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.00 to $13.09, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.

Issuer

KalVista Pharmaceuticals, Inc.

CIK 0001348911

Entity typeother

Related Parties

1
  • filerCIK 0001691090

Filing Metadata

Form type
4
Filed
Jan 11, 7:00 PM ET
Accepted
Jan 12, 4:26 PM ET
Size
5.8 KB